| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2021 1st Quarter - Report |
ML STRATEGIES, LLC | SORRENTO THERAPEUTICS, INC. | $50,000 | |
| 2021 1st Quarter - Report |
ML STRATEGIES, LLC | KARL STORZ ENDOSCOPY - AMERICA, INC | $60,000 | |
| 2020 4th Quarter - Report |
ML STRATEGIES, LLC | KARL STORZ ENDOSCOPY - AMERICA, INC | $60,000 | |
| 2020 3rd Quarter - Report |
ML STRATEGIES, LLC | MSS, INC. (ON BEHALF OF SHANGHAI LIANGRUN BIOMEDI… | $50,000 | |
| 2020 3rd Quarter - Report |
ML STRATEGIES, LLC | IMMUNOMIC THERAPEUTICS | $30,000 | |
| 2020 3rd Quarter - Report |
ML STRATEGIES, LLC | CONTINUUS PHARMACEUTICALS | $30,000 | |
| 2020 3rd Quarter - Report |
ML STRATEGIES, LLC | UMBULIZER | — | |
| 2020 3rd Quarter - Report |
ML STRATEGIES, LLC | KARL STORZ ENDOSCOPY - AMERICA, INC | $60,000 | |
| 2020 Registration |
ML STRATEGIES, LLC | CONTINUUS PHARMACEUTICALS | — | |
| 2020 Registration |
ML STRATEGIES, LLC | MSS, INC. (ON BEHALF OF SHANGHAI LIANGRUN BIOMEDI… | — |